Dysregulated Lymphokine Production in Systemic Lupus Erythematosus (SLE)
- 28 June 1989
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 557 (1) , 567-569
- https://doi.org/10.1111/j.1749-6632.1989.tb24068.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2‐dependent cell line and preparation of anti‐IL 6 monoclonal antibodiesEuropean Journal of Immunology, 1988
- Abnormal Production of and Response to B‐Cell Growth Factor and B‐Cell Differentiation Factor in Patients with Systemic Lupus ErythematosusScandinavian Journal of Immunology, 1985
- Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.Journal of Clinical Investigation, 1985
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).The Journal of Immunology, 1983
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1982
- Gene segments encoding transmembrane carboxyl termini of immunoglobulin γ chainsCell, 1981
- Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, 1980
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978